Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2

<i><b>Background/Objectives</b></i>: Our previous study demonstrated that while the third SARS-CoV-2 booster effectively enhanced immunity against the Delta subvariant, its protection declined over time. This study aimed to evaluate and compare the humoral and cellular immune responses, as well as r...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Auchara Tangsathapornpong, Sira Nanthapisal, Waraphon Fukpho, Pornumpa Bunjoungmanee, Yamonbhorn Neamkul, Kanassanan Pontan, Arthit Boonyarangkul, Supattra Wanpen, Kanokporn Thongphubeth, Phuntila Tharabenjasin, Peera Jaru-Ampornpan
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2026-04-01
Cyfres:	Vaccines
Pynciau:	SARS-CoV-2 vaccine CoronaVac AZD1222 BNT162b2 mRNA-1273 booster dose
Mynediad Ar-lein:	https://www.mdpi.com/2076-393X/14/4/348
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!